Work

Efficacy and safety of sunitinib malate (SU11248) in bevacizumab-refractory metastatic renal cell carcinoma (mRCC)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.4522

Authors: B. I. Rini, D. J. George, M. D. Michaelson, J. E. Rosenberg, R. M. Bukowski, J. A. Sosman, W. M. Stadler, K. Margolin, T. E. Hutson, C. M. Baum

Institutions: Cleveland Clinic, Duke University, University of California, San Francisco, Vanderbilt University, University of Chicago, Massachusetts General Hospital

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2217399048

Cites:

Cited by: 54

Related to: 10